CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹13 Cr | ₹7.89 Cr | ₹2.13 Cr | ₹13 Cr | ₹17 Cr |
What is the latest Total Non-Current Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹7.89 Cr |
| Mar2023 | ₹2.13 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹17 Cr |
How is Total Non-Current Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 67.81 | |
| Mar2024 | ₹7.89 Cr | 270.42 | |
| Mar2023 | ₹2.13 Cr | -83.03 | |
| Mar2022 | ₹13 Cr | -27.83 | |
| Mar2021 | ₹17 Cr | - | |
Compare Total Non-Current Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹13,663.3 Cr | -6.3% | -6.5% | -27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,782.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,376.0 Cr | -1.3% | -1.2% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,225.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,174.0 Cr | -0.3% | -1.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,629.0 Cr | -1.2% | -1.8% | -7.7% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -6.3% |
-6.5% |
-27.4% |
| SENSEX | -0.3% |
-0.5% |
8.3% |
You may also like the below Video Courses